HOWL
Price
$1.36
Change
-$0.01 (-0.73%)
Updated
Jul 25 closing price
Capitalization
61.03M
10 days until earnings call
PHVS
Price
$20.62
Change
+$0.57 (+2.84%)
Updated
Jul 25 closing price
Capitalization
1.32B
Earnings call today
Interact to see
Advertisement

HOWL vs PHVS

Header iconHOWL vs PHVS Comparison
Open Charts HOWL vs PHVSBanner chart's image
Werewolf Therapeutics
Price$1.36
Change-$0.01 (-0.73%)
Volume$124.72K
Capitalization61.03M
Pharvaris
Price$20.62
Change+$0.57 (+2.84%)
Volume$709.62K
Capitalization1.32B
HOWL vs PHVS Comparison Chart in %
Loading...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOWL vs. PHVS commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOWL is a StrongBuy and PHVS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (HOWL: $1.36 vs. PHVS: $20.62)
Brand notoriety: HOWL and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOWL: 24% vs. PHVS: 617%
Market capitalization -- HOWL: $61.03M vs. PHVS: $1.32B
HOWL [@Biotechnology] is valued at $61.03M. PHVS’s [@Biotechnology] market capitalization is $1.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOWL’s FA Score shows that 1 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • HOWL’s FA Score: 1 green, 4 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, both HOWL and PHVS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOWL’s TA Score shows that 5 TA indicator(s) are bullish while PHVS’s TA Score has 4 bullish TA indicator(s).

  • HOWL’s TA Score: 5 bullish, 5 bearish.
  • PHVS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HOWL is a better buy in the short-term than PHVS.

Price Growth

HOWL (@Biotechnology) experienced а -3.55% price change this week, while PHVS (@Biotechnology) price change was -11.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

HOWL is expected to report earnings on Aug 07, 2025.

PHVS is expected to report earnings on Jul 28, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($1.32B) has a higher market cap than HOWL($61M). PHVS YTD gains are higher at: 7.564 vs. HOWL (-8.108). HOWL has higher annual earnings (EBITDA): -65.72M vs. PHVS (-159.25M). PHVS has more cash in the bank: 236M vs. HOWL (92M). PHVS has less debt than HOWL: PHVS (741K) vs HOWL (37M). HOWL has higher revenues than PHVS: HOWL (1.14M) vs PHVS (0).
HOWLPHVSHOWL / PHVS
Capitalization61M1.32B5%
EBITDA-65.72M-159.25M41%
Gain YTD-8.1087.564-107%
P/E RatioN/AN/A-
Revenue1.14M0-
Total Cash92M236M39%
Total Debt37M741K4,993%
TECHNICAL ANALYSIS
Technical Analysis
HOWLPHVS
RSI
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 12 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVACX39.200.15
+0.38%
JPMorgan Value Advantage C
WIMVX12.150.04
+0.33%
Segall Bryant & Hamill Glb All Cp Inst
ALBCX82.480.24
+0.29%
Alger Growth & Income C
GQHIX13.140.02
+0.15%
GQG Partners US Quality Value Fund Ins
VCIEX9.35-0.07
-0.74%
VALIC Company I International Eqs Idx

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with CLDX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-0.73%
CLDX - HOWL
42%
Loosely correlated
+0.56%
IPSC - HOWL
41%
Loosely correlated
-5.17%
SYRE - HOWL
41%
Loosely correlated
+1.08%
GBIO - HOWL
40%
Loosely correlated
+9.76%
ABOS - HOWL
39%
Loosely correlated
N/A
More

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with INKT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
+2.84%
INKT - PHVS
34%
Loosely correlated
-2.32%
HOWL - PHVS
33%
Poorly correlated
-0.73%
SNDX - PHVS
30%
Poorly correlated
-3.60%
MGTX - PHVS
30%
Poorly correlated
+0.72%
CELC - PHVS
30%
Poorly correlated
-1.99%
More